Cargando…
Mutagenicity and safety pharmacology of a standardized antidiabetic polyherbal formulation
Synacinn is a standardized polyherbal extract formulated for the treatment of diabetes mellitus and its complications. This study aims to assess the mutagenicity potential of Synacinn by Ames assay and in vivo bone marrow micronucleus (MN) test on Sprague Dawley rat. Human ether-a-go-go-related gene...
Autores principales: | Abdul Majid, Fadzilah Adibah, Fadhlina, Anis, Ismail, Hassan Fahmi, Zainol, Siti Nurazwa, Mamillapalli, Archan Kumar, Venkatesan, Vijayabalaji, Eswarappa, Rajesh, Pillai, Renuka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065066/ https://www.ncbi.nlm.nih.gov/pubmed/35505003 http://dx.doi.org/10.1038/s41598-022-11243-3 |
Ejemplares similares
-
Analytical method cross validation by HPLC for identification of five markers and quantification of one marker in Synacinn(TM) formulations and its in vivo bone marrow micronucleus test data
por: Zainol, Siti Nurazwa, et al.
Publicado: (2021) -
Synacinn™: Bacterial reverse mutation test data in five histidine-requiring strains of Salmonella Typhimurium
por: Zainol, Siti Nurazwa, et al.
Publicado: (2021) -
Standardization of some herbal antidiabetic drugs in polyherbal formulation
por: Chandel, Harinarayan Singh, et al.
Publicado: (2011) -
Molecular docking analysis and anti-hyperglycaemic activity of Synacinn™ in streptozotocin-induced rats
por: Ab Rahman, Nur Syukriah, et al.
Publicado: (2020) -
Development of polyherbal antidiabetic formulation encapsulated in the phospholipids vesicle system
por: Gauttam, Vinod Kumar, et al.
Publicado: (2013)